Related references
Note: Only part of the references are listed.Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
Per Soelberg Sorensen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
Richard A. Rudick et al.
ANNALS OF NEUROLOGY (2010)
JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab
Caroline F. Ryschkewitsch et al.
ANNALS OF NEUROLOGY (2010)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
JCV detection in multiple sclerosis patients treated with natalizumab
Saud A. Sadiq et al.
JOURNAL OF NEUROLOGY (2010)
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Luciano Rinaldi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy
Chen S. Tan et al.
JOURNAL OF VIROLOGY (2010)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
Samantha Jilek et al.
LANCET NEUROLOGY (2010)
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Joseph R. Berger et al.
ANNALS OF NEUROLOGY (2009)
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Kenneth R. Carson et al.
LANCET ONCOLOGY (2009)
Determinants of survival in progressive multifocal leukoencephalopathy
A. Marzocchetti et al.
NEUROLOGY (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
Fabian Zohren et al.
BLOOD (2008)
Thinking without thinking about natalizumab and PML
Richard M. Ransohoff
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Reactivation of JC virus and development of PML in patients with multiple sclerosis
K. Khalili et al.
NEUROLOGY (2007)
Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects
Andrea Rossi et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters
G Magri et al.
VACCINE (2005)
A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine
S Delbue et al.
JOURNAL OF NEUROVIROLOGY (2005)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals
RA Du Pasquier et al.
JOURNAL OF VIROLOGY (2004)
Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children
C Polo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Traffic of JC virus from sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy
BF Sabath et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Molecular biology and immunoregulation of human neurotropic JC virus in CNS
TM Sweet et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy
L Andreoletti et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy
IJ Koralnik et al.
JOURNAL OF VIROLOGY (2001)
Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: Effects on cerebrospinal fluid markers of JC virus replication and immune response
B Giudici et al.
CLINICAL INFECTIOUS DISEASES (2000)